Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03014544 · ClinicalTrials.gov registry record
Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 585
- Enrollment target
NCT03014544 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 585 participants.
The verdict
NCT03014544 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 585 participants
- Enrollment target
Study Summary
The purpose of this study is to examine concurrent validity of 8 computerized tests intended for the assessment of cognitive function in participants with Major Depressive Disorder (MDD), relative to 8 corresponding and previously validated examiner-administered cognitive tests.
Interventions
- DEVICE Computer- administered test battery
- DEVICE Examiner- administered test battery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2016-10-26 |
| Est. Completion | 2019-04-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03014544
The ClinicalTrials.gov registry entry for NCT03014544 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 585 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Computer- administered test battery is the first listed.
NCT03014544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03014544 about?
NCT03014544 is a clinical study titled "Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD)". The purpose of this study is to examine concurrent validity of 8 computerized tests intended for the assessment of cognitive function in participants with Major Depressive Disorder (MDD), relative to 8 corresponding and previously validated examiner-administered cognitive tests.
What is the current status of trial NCT03014544?
This trial is currently completed. The enrollment target is 585 participants. The study started on 2016-10-26. Estimated completion is 2019-04-08.
What interventions are being tested in trial NCT03014544?
The interventions under investigation include: Computer- administered test battery (DEVICE), Examiner- administered test battery (DEVICE).
Who is sponsoring clinical trial NCT03014544?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.